MarketPeel
Insider Trading Intelligence
DB

D. Fraser Bullock

HCAT
DIRECTOR · HEALTH CATALYST, INC. · CIK 0001366853
FILING MIX · LIFETIME36%/64%
BUYS
4
SELLS
7
TOTAL VALUE
$1.11M
COMPANIES
1
ACTIVE SINCE
Feb 2020
HOLDINGS NOW
44,999
AVG SELL PX
$37.16
TRADE KIND
SHOWING 11 / 11
Trades · vs SPY
Loading price series…
Performance · forward returns vs SPY
5 backtested trades · 8 horizonsHow are these numbers computed? →
Forward-return performance of every backtestable P/S trade by D. Fraser Bullock, measured at 8 horizons from 7 days to 2 years. Deduped per economic event so co-filings count once. Excess return = trade return minus SPY return over the same window.
HORIZONTRADESWIN RATEINSIDER RETURNSPY RETURNMEAN EXCESSMEDIAN EXCESST-STAT
7d5+60.00%+0.55%+1.89%-1.33%-4.46%
14d5+80.00%+0.41%+2.96%-2.55%-5.75%
30d5+80.00%-5.48%+2.38%-7.87%-4.85%
60d5+60.00%+5.46%+5.11%+0.36%-4.50%
90d5+40.00%+10.67%+7.42%+3.25%+6.12%
180d5+0.00%+36.27%+18.45%+17.82%+19.63%
1y5+0.00%+37.62%+32.69%+4.94%+4.82%
2y5+100.00%-65.33%+18.25%-83.58%-83.85%
How to read this: Insider Returnis the average raw return of the filer's trades over the horizon. SPY Return is what SPY did over those same windows — reference only, not a comparison. The headline alpha number is Mean Excess = Insider − SPY; green means the filer beat SPY, red means they trailed it. Win rate is the share of individual trades where the filer beat SPY. T-statvalues above 2 mean the alpha is unlikely to be chance given the sample size. "Pending" counts trades where the horizon hasn't elapsed yet; their stats are not included in the row average.
Holdings over time
HCAT · 44,999 shares · as of Jun 10, 2021
0152,286304,572456,857609,1432021SHARES HELD
Trading cadence · quarterly flow
BUY SELL
2020
2020
2020
2020
2021
2021
FLOW · 4 buys / 7 sellsCOVERAGE · 6 quarters
Form 4 filings · all activity
COMPANYTYPESHARESPRICEVALUEHELD AFTERTRADE DATEFILEDDETAILS
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
3,28544,999Jun 10, 2021Jun 14, 2021View →
HCAT
HEALTH CATALYST, INC.
SALE
25,777$37.19$958.6K41,714Dec 4, 2020Dec 8, 2020View →
HCAT
HEALTH CATALYST, INC.
SALE
1,700$37.01$62.9K67,491Oct 2, 2020Oct 7, 2020View →
HCAT
HEALTH CATALYST, INC.
SALE
423$37.00$15.7K69,191Oct 1, 2020Oct 2, 2020View →
HCAT
HEALTH CATALYST, INC.
SALE
400$37.00$14.8K69,614Jul 28, 2020Jul 29, 2020View →
HCAT
HEALTH CATALYST, INC.
SALE
1,700$37.01$62.9K70,014Jul 27, 2020Jul 29, 2020View →
HCAT
HEALTH CATALYST, INC.
PURCHASEGRANT
Stock grant
5,44371,714Jun 12, 2020Jun 17, 2020View →
HCAT
HEALTH CATALYST, INC.
PURCHASE
29,48266,271Feb 14, 2020Feb 19, 2020View →
HCAT
HEALTH CATALYST, INC.
SALE
609,1430Feb 14, 2020Feb 19, 2020View →
HCAT
HEALTH CATALYST, INC.
SALE
609,144609,143Feb 5, 2020Feb 7, 2020View →
HCAT
HEALTH CATALYST, INC.
PURCHASE
33,23236,789Feb 5, 2020Feb 7, 2020View →
Other insiders · HCAT
Loading peer insiders…
About this filer
CIK 0001366853
ROLE
Director
PRIMARY
HCAT
COMPANIES
1
ACTIVE SINCE
Feb 2020
MARKETPEEL · /INSIDER/0001366853DATA · SEC EDGAR · FORM 4 · CONSOLIDATED TAPE
FREE · DAILY · 6 AM ET

One short email. Insider buys, congressional trades, and plain-English analysis.

Feedback